Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate
Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate
Nephros 2024 年第一季度公认会计准则每股收益 (0.02) 超过预期 (0.04) 美元，销售额352.2万美元，低于373.4万美元的预期
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $3.522 million which missed the analyst consensus estimate of $3.734 million by 5.68 percent. This is a 4.73 percent decrease over sales of $3.697 million the same period last year.
Nephros（纳斯达克股票代码：NEPH）公布的季度亏损为每股0.02美元，比分析师普遍预期的0.04美元（0.04美元）高出50％。与去年同期每股亏损0.03美元（0.03）相比，增长了33.33％。该公司公布的季度销售额为352.2万美元，比分析师普遍预期的373.4万美元低5.68％。这比去年同期的369.7万美元的销售额下降了4.73％。